Mechanisms Behind Development of Tendinopathy
TESINaC
1 other identifier
observational
400
1 country
1
Brief Summary
There has been an increasing amount of musculoskeletal injuries the past decades and overused tendons represents a major problem both for leisure and occupational activities. A full understanding of the pathophysiology of tendinopathy is very sparse and especially the early events in tendinopathy remains unexplained. In this phd study the investigators will investigate early changes in tendon tissue overloading and development of tendinopathy. The investigators will investigate sports-active individuals with recently developed tendinopathy with regards to symptoms (pain, function), tendon morphology (ultrasonography, MRI and electron microscopy), tendon mechanical properties (ultrasonography strain), tissue molecular biology (expression and content of matrix proteins), inflammation (activity of inflammatory pathways) and vascularization (Doppler and contrast enhancement US). The investigators hypothesize a coupling between early symptoms and inflammatory activity, followed by structural changes and altered mechanical properties. The investigation will indicate what symptoms and what tendon related determined measurements are primary for disease development ("tendinopathy blue prints") and should be regarding vital in prevention of tendinopathy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2016
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2016
CompletedFirst Submitted
Initial submission to the registry
June 2, 2016
CompletedFirst Posted
Study publicly available on registry
June 14, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2020
CompletedJanuary 19, 2018
January 1, 2018
3 years
June 2, 2016
January 18, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Investigate the timespan of inflammation from acute phase to resolution in tendinopathy
Markers for inflammation includes tendon thickness, vascularization, inflammatory mRNA leves, inflammatory protein signals and mechanical properties of tendon.
3 months
Secondary Outcomes (6)
Measure tendon thickness in mm (anterior-posterior) on ultrasound
3 months
Measure TNF-alpha mRNA levels in patella biopsies as ratio to GAPDH
3 months
Measure the tendon region with maximal vascularization on ultrasound doppler signal based on visual impression from the investigators
3 months
IHC stain for TNF-alpha protein signal in patella biopsies with specific antibodies
3 month
Measure tendon mechanical properties with ultrasound isometric
3 months
- +1 more secondary outcomes
Study Arms (2)
Tendinopathy
Long slow strength training for 3 months that are performed at home or gym. Participants receive initial guidance to the exercises from a physiotherapist assigned to Bispebjerg H.
Healthy
No intervention. No training
Interventions
Long slow strength training of the tendon for 3 months to improve function
Eligibility Criteria
Physical active participants over 18 years old, both men and women. The term physical active refers to any kind of sport and not only running. Participants with pain in either Achilles or patellar tendon on one leg. Healthy participants must be symptom free and not have any diseases at all.
You may qualify if:
- Marked tendon related pain in association with exercise on one leg
- Soreness during physical examination of patella or/and Achilles tendon upon palpation
- Demonstrate an ultrasonographic (US) thickening of the tendon (2 mm larger on the affected side vs the contralateral un-symptomatic side in the anterior-posterior projection)
You may not qualify if:
- Surgery in Achilles and/or patella tendon
- History of Achilles and/or patella tendinopathy
- Received any form of injection in Achilles and/or patella tendon
- Lately have infection around Achilles and/or patella tendon
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Bispebjerg Hospitallead
- University of Copenhagencollaborator
Study Sites (1)
Bispebjerg Hospital
Copenhagen, Kbh NV, 2400, Denmark
Biospecimen
Whole blood, serum, plasma and tissue.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Michael Kjær, Professor
Clinical Medicine
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor, phd student
Study Record Dates
First Submitted
June 2, 2016
First Posted
June 14, 2016
Study Start
June 1, 2016
Primary Completion
June 1, 2019
Study Completion
June 1, 2020
Last Updated
January 19, 2018
Record last verified: 2018-01
Data Sharing
- IPD Sharing
- Will not share